Related Experiment Video
Updated: Jul 28, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Prognostic factors predicting control of chronic asthma symptoms in children receiving prophylactic bronchodilator
Insights
Asthma symptom control improved over time with bronchodilator therapy. However, a history of exacerbations due to fear, dust, or cold stimuli predicted poorer asthma symptom control in children.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
Background:
- Chronic asthma affects a significant number of children.
- Effective management of pediatric asthma requires understanding predictive factors for treatment success.
- Prophylactic bronchodilator therapy is a common treatment approach.
Purpose of the Study:
- To identify factors that predict the control of asthma symptoms in children undergoing chronic prophylactic bronchodilator therapy.
- To evaluate the impact of specific stimuli (fear, dust, cold) on asthma symptom control over time.
Main Methods:
- A cohort of 312 children with chronic asthma receiving prophylactic bronchodilator therapy was studied.
- Asthma symptom control was assessed over an 18-month period.
- Statistical analysis was used to determine the association between patient history and symptom control.
Main Results:
- Asthma symptoms were controlled in 74.4% of patients after 18 months.
- A history of symptom exacerbation by fear stimulus was associated with an 83.3% lower rate of control (p=0.0001).
- A history of symptom exacerbation by dust (35.4%, p=0.003) or cold foods/drinks (71.4%, p=0.002) also predicted lower control rates.
Conclusions:
- The duration of therapy positively influences asthma symptom control.
- Specific triggers like fear, dust, and cold are significant predictors of poorer asthma control in children.
- Airway lability to certain stimuli plays a crucial role in predicting treatment outcomes for pediatric asthma.
Abstract:
The factors predicting the control of asthma symptoms were studied in 312 consecutive children with chronic asthma who were receiving chronic prophylactic bronchodilator therapy. Asthma symptoms were controlled in 232 (74.4%) patients but not in 80 (25.6%) patients after 18 months of therapy. The cumulative percentage of patients in whom asthma symptoms were controlled increased with the duration of therapy. During the first 6 months of therapy, children who had a history of exacerbation of symptoms by fear stimulus or by dust had respectively an 83.3% (p = 0.0001) and a 35.4% (p = 0.003) lower rate of control of asthma symptoms than children without such a history. Similarly, children with a history of worsening asthma symptoms following ingestion of cold foods or drinks had a 71.4% (p = 0.002) lower rate of control of asthma symptoms after 6-12 months of therapy than children without such a history. Certain factors are important for predicting control of asthma symptoms at different times following the initiation of therapy and may relate to the lability of the airways to these stimuli.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

